Inducing neutrophil recruitment in the liver of ICAM-1-deficient mice using polyethyleneimine grafted with Pluronic P123 as an organ-specific carrier for transgenic ICAM-1
- 27 June 2002
- journal article
- Published by Springer Nature in Gene Therapy
- Vol. 9 (14), 939-945
- https://doi.org/10.1038/sj.gt.3301716
Abstract
At the forefront of medicine, Gene Therapy brings you the latest research into genetic and cell-based technologies to treat disease. It also publishes Progress & Prospects reviews and News and Commentary articles, which highlight the cutting edge of the field.Keywords
This publication has 35 references indexed in Scilit:
- Intratumoral Administration of Adenoviral Interleukin 7 Gene-Modified Dendritic Cells Augments Specific Antitumor Immunity and Achieves Tumor EradicationHuman Gene Therapy, 2000
- Adenoviral Vectors Expressing Lymphotactin and Interleukin 2 or Lymphotactin and Interleukin 12 Synergize to Facilitate Tumor Regression in Murine Breast Cancer ModelsHuman Gene Therapy, 1999
- Liver Metastases Are Enhanced in Homozygous Deletionally Mutant ICAM-1 or LFA-1 MiceJournal of Surgical Research, 1998
- In vivoinduction of functional FcγRI (CD64) on neutrophils and modulation of blood cytokine mRNA levels in cancer patients treated with G-CSF (rMetHuG-CSF)British Journal of Haematology, 1998
- Cytotoxic activity against tumour cells mediated by intermediate TCR cells in the liver and spleenImmunology, 1996
- Microvascular expression of mala‐2 correlates with In vivo lymphocyte trafficking and is preferentially enhanced in tumors by tumor necrosis factor‐α and interleukin‐1αInternational Journal of Cancer, 1994
- Leukocytosis and resistance to septic shock in intercellular adhesion molecule 1-deficient mice.The Journal of Experimental Medicine, 1994
- Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigmCell, 1994
- Specific Acceptance of Cardiac Allograft After Treatment with Antibodies to ICAM-1 and LFA-1Science, 1992
- Analysis of T cell stimulation by superantigen plus major histocompatibility complex class II molecules or by CD3 monoclonal antibody: costimulation by purified adhesion ligands VCAM-1, ICAM-1, but not ELAM-1.The Journal of Experimental Medicine, 1991